AGPAT5 and hepatocellular carcinoma: Similarly, LCLAT1 expression was recently found to be upregulated in hepatocellular carcinoma (HCC), compared to normal liver tissue, and along with AGPAT5 and LPCAT1, was identified as a highly sensitive biomarker that correlated with worse prognosis and overall survival.59